WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
Diabetes Management Platform | Type 1 & 2 Diabetes Patients | News, Analysis, Insights - HIT Consultant
Livongo Health Pulls In $45M to Expand Diabetes Management
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $44.5 million in Series C funding from investors including Merck Global Health Innovation Fund; Cowen Private Investments; Sapphire Ventures; Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts; Wanxiang America Corporation. Existing investors General Catalyst, Kleiner Perkins Caufield & Byers (KPCB), DFJ, and 7wire Ventures. also
Read More
Glooko Launches Office Kiosk for In-Clinic Diabetes Care
Glooko Inc., a unified platform for diabetes management, today announced the official launch of its “Glooko Office Kiosk” package to redefine in-clinic diabetes care experience for patients with diabetes and healthcare professionals by bringing insights that drive teachable moments to patient-clinician interactions
For the first time, Glooko Office Kiosk enables diabetes data from popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs) to be synced to an Android
Read More
